blood cancer

Showing 2 posts of 32 posts found.

Rituxan gains approval for most common leukaemia

February 19, 2010
Sales and Marketing FDA, MabThera, Rituxan, blood cancer

Roche’s blockbuster cancer treatment MabThera/Rituxan has been approved by the FDA for the treatment of adult leukaemia. The drug earned …

The Gateway to Local Adoption Series

Latest content